Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00208936
Status:
TERMINATED
Last Update Posted:
2014-09-09
First Post:
2005-09-13
Brief Title:
Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
Sponsor:
Emory University
Organization:
Emory University
Study Overview
Official Title:
Phase II Study of Pre-Operative Chemotherapy With Taxol Cisplatin and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus
Status:
TERMINATED
Status Verified Date:
2014-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed pre-operative for patients with resectable local-regional carcinoma of the esophagus
Detailed Description:
This study is designed for patients with resectable local-regional carcinoma of the esophagus In a pre-operative setting chemotherapy with Taxol Cisplatin and 5-Fluorouracil will be administered followed by G-CSF
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None